
White House mulls next steps for FDA nominee who faces bipartisan resistance
Some Trump administration officials are increasingly skeptical about the Senate confirmation of Heidi Overton to head the Food and Drug Administration, prompting them to discuss whether to try to shore up her nomination or abandon it altogether, according to four people familiar with the matter who spoke on the condition of anonymity to discuss a personnel matter.
Gn usa